Michael B. Hoffman's Insider Trades & SAST Disclosures
Michael B. Hoffman's most recent trade in Annovis Bio Inc was a trade of 163,880 Common Stock done at an average price of $6.1 . Disclosure was reported to the exchange on Nov. 20, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael B. Hoffman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 20 Nov 2023 | 163,880 | 223,357 (3%) | 2% | 6.1 | 999,668 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 29,600 | 29,600 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 12.61 per share. | 07 Apr 2023 | 59,477 | 59,477 (0%) | 0% | 12.6 | 750,005 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 6,820 | 6,820 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.39 per share. | 03 Jan 2022 | 30,000 | 1,415,889 (21%) | 0% | 4.4 | 131,700 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 9,000 | 9,000 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 7,142 | 0 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.25 per share. | 03 Jan 2022 | 7,142 | 1,416,373 (21%) | 0% | 0.3 | 1,786 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. | 03 Jan 2022 | 6,658 | 1,409,231 (21%) | 0% | 19.8 | 131,695 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. | 03 Jan 2022 | 90 | 1,416,283 (21%) | 0% | 19.8 | 1,780 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc. | Michael M.B. Hoffman | Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 27 Aug 2020 | 182,492 | 21,919 (0%) | 0% | 0.3 | 49,620 | Common Stock |
| Traws Pharma Inc. | Michael M.B. Hoffman | Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 27 Aug 2020 | 1,876 | 0 (0%) | 0% | 0.3 | 510 | Common Stock |
| Traws Pharma Inc. | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges